Research programme: ER stress response modulators - Aravive
Alternative Names: 2-series; 4-series ER stressLatest Information Update: 03 May 2024
At a glance
- Originator
- Developer Aravive Biologics
- Class Antineoplastics
- Mechanism of Action Cell physiology modulators; Protein folding modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Multiple myeloma